Here, we investigated the effect of LRRK2 missense variants on PD only, CD only, UC only, IBD only, and the co-occurrence of IBD and PD risk (IBD-PD) using sequencing data from the Danish Registry, the Mount Sinai BioMe BioBank, and the UK Biobank. Here, LRRK2 is linked to inflammatory bowel disease.